Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 3/20 | 0.54 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.47 |
| ▸ | PDE2A | O00408 | 1/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 6/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.40 |
| ▸ | PIM1 | P11309 | 1/20 | 0.40 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.40 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.39 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.39 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.38 |
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.37 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.37 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23519097 | 0.82 | CES2 (0.41) | FFAR4FFAR1PIM1PPARANOTUM | |
| SCHEMBL23519065 | 0.80 | EPHX2 (0.55) | EPHX2PIM1MRGPRX4NOTUM | |
| SCHEMBL19556095 | 0.80 | PPARD (0.52) | EPHX2SLC7A5FFAR4FFAR1PPARD | |
| SCHEMBL30112070 | 0.80 | PPARD (0.52) | EPHX2SLC7A5FFAR4FFAR1PPARD | |
| SCHEMBL14596842 | 0.79 | SLC7A5 (0.52) | EPHX2SLC7A5PDE2AFFAR4FFAR1 | |
| SCHEMBL28958691 | 0.79 | EPHX2 (0.53) | EPHX2SLC7A5PDE2APIM1SCN9A | |
| SCHEMBL23519082 | 0.78 | PPARA (0.48) | FFAR4FFAR1MRGPRX4PPARA | |
| SCHEMBL17186832 | 0.77 | EPHX2 (0.46) | EPHX2NOTUMSCN8ASCN10A | |
| SCHEMBL29795192 | 0.77 | EPHX2 (0.46) | EPHX2NOTUMSCN8ASCN10A | |
| SCHEMBL23519071 | 0.77 | NOTUM (0.47) | FFAR1PIM1MRGPRX4NOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210179554-A1 | ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210179554-A1 | ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SLC6A5, LIFR, SLC6A9 | EPHX2 3804/4885SLC7A5 122/4885PDE2A 4233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.